Corcept Therapeutics Inc.

CORT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Mar 4, 2026 4
4 Mar 4, 2026 4
144 Mar 4, 2026
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Mar 3, 2026 4
4 Feb 26, 2026 4
10-K Feb 24, 2026 10-K
8-K Feb 24, 2026 8-K
8-K Feb 19, 2026 8-K
4 Feb 13, 2026 4
SCHEDULE 13G/A Feb 12, 2026
4 Feb 11, 2026 4
4 Feb 5, 2026 4
144 Feb 3, 2026
4 Jan 29, 2026
8-K Jan 22, 2026 8-K
4 Jan 8, 2026 4
144 Jan 6, 2026
4 Jan 5, 2026
8-K Dec 31, 2025 8-K
← Newer Page 5 of 82 · 2035 filings Older →